Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EZH2 |
| Upstream (Parents) |
|---|
| (<<) KIF18B → EZH2 |
| (<<) DLGAP5 → EZH2 |
| (<<) MCM7 → EZH2 |
| Downstream (Children) |
|---|
| EZH2 → RPP25 (>>) |
| EZH2 → TLE3 (>>) |
| EZH2 → NCAPG2 (>>) |
| EZH2 → LOC81691 (>>) |
| EZH2 → RNASE3 (>>) |
| EZH2 → MCM7 (>>) |
| EZH2 → OSBPL10 (>>) |
| EZH2 → GTSE1 (>>) |
| EZH2 → INADL (>>) |
| EZH2 → AVPR2 (>>) |
| EZH2 → UBE2O (>>) |
| EZH2 → PAK1 (>>) |
| EZH2 → WDR60 (>>) |
| EZH2 → DDX11 (>>) |
| EZH2 → TACC3 (>>) |
